Expanded Conventional First Trimester Screening

Prenat Diagn. 2017 Aug;37(8):802-807. doi: 10.1002/pd.5090. Epub 2017 Jul 18.

Abstract

Objective: The study aims to determine the performance of a five (5) serum marker plus ultrasound screening protocol for T21, T18 and T13.

Method: Specimens from 331 unaffected, 34 T21, 19 T18 and 8 T13 cases were analyzed for free Beta human chorionic gonadotropin, pregnancy-associated plasma protein A, alpha-fetoprotein, placental growth factor and dimeric inhibin A. Gaussian distributions of multiples of the median values were used to estimate modeled false positive and detection rates (DR).

Results: For T21, at a 1/300 risk cut-off, DR of screening with all five serum markers along with nuchal translucency and nasal bone was 98% at a 1.2% false positive rate (FPR). Using a 1/1000 cut-off, the DR was 99% with a 2.6% FPR. For T18/13 with free Beta human chorionic gonadotropin, pregnancy-associated plasma protein A, placental growth factor and nuchal translucency at a 1/150 cut-off, DR was 95% at a 0.5% FPR while at a 1/500 risk cut-off, DR was 97% at a 1.2% FPR.

Conclusion: An expanded conventional screening test can achieve very high DRs with low FPRs. Such screening fits well with proposed contingency protocols utilizing cell-free DNA as a secondary or reflex but also provides the advantages of identification of pregnancies at risk for other adverse outcomes such as early-onset preeclampsia. © 2017 Eurofins NTD, LLC. Prenatal Diagnosis published by John Wiley & Sons, Ltd.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aneuploidy*
  • Biomarkers / blood*
  • Case-Control Studies
  • Female
  • Humans
  • Maternal Serum Screening Tests*
  • Pregnancy
  • Young Adult

Substances

  • Biomarkers